Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 USD | 0.00% | +4.29% | -36.71% |
07/03 | Transcript : Nephros, Inc., Q4 2023 Earnings Call, Mar 07, 2024 | |
07/03 | Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 16.7M 1.39B | Sales 2025 * | 18.79M 1.57B | Capitalization | 23.09M 1.93B |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | - 0 | EV / Sales 2024 * | 1.38 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.23 x |
P/E ratio 2024 * |
-33.7
x | P/E ratio 2025 * |
219
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.77% |
Latest transcript on Nephros, Inc.
1 week | +4.29% | ||
1 month | -3.52% | ||
3 months | -38.83% | ||
6 months | +36.02% | ||
Current year | -36.71% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 31/23/31 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | 01/11 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 19/07/19 |
Oliver Spandow
BRD | Director/Board Member | 52 | 10/18/10 |
Alisa Lask
BRD | Director/Board Member | 53 | 08/19/08 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.19 | 0.00% | 4,904 |
24/24/24 | 2.19 | +2.34% | 7,314 |
23/24/23 | 2.14 | +2.39% | 1,242 |
22/24/22 | 2.09 | -0.48% | 26,048 |
19/24/19 | 2.1 | +3.45% | 9,212 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.71% | 23.09M | |
+10.59% | 8.7B | |
+29.45% | 2.21B | |
-0.24% | 1.18B | |
+24.85% | 883M | |
-2.50% | 808M | |
-14.90% | 600M | |
+3.40% | 594M | |
-2.33% | 565M | |
-8.50% | 553M |
- Stock Market
- Equities
- NEPH Stock